Mechanisms of Disease: the complement system in renal injury - new ways of looking at an old foe

被引:29
作者
Brown, Katherine M. [1 ]
Sacks, Steven H. [1 ]
Sheerin, Neil S. [1 ]
机构
[1] Kings Coll London, Dept Nephrol & Transplantat, Guys Hosp, London SE1 9RT, England
来源
NATURE CLINICAL PRACTICE NEPHROLOGY | 2007年 / 3卷 / 05期
基金
英国医学研究理事会;
关键词
chronic kidney disease; complement; hemolytic uremic syndrome; inflammation; transplantation immunology;
D O I
10.1038/ncpneph0465
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The fact that the complement system is activated during immune-complex glomerular disease has been known for nearly 50 years. Detection of complement deposition in the glomerulus using immunochemistry has become an important element of the histological analysis of renal biopsies, and is key to the diagnosis of many types of glomerulonephritis. In recent years it has become evident that complement activation is involved in the pathogenesis of other types of renal disease; complement activation is implicated in transplant injury, atypical hemolytic uremic syndrome and progressive tubulointerstitial fibrosis. Emergence of this evidence has provided insight into how these diseases develop, and has yielded useful diagnostic tools and potential targets for therapeutic intervention. Clinicians have, by using plasma-based therapies, unknowingly treated abnormalities of the complement system in renal patients for many years. Advances in antibody and protein technologies have led to the development of complement inhibitors that have been used in phase III clinical studies. More-specific agents and applications are likely to be developed over the coming years and are discussed in this Review.
引用
收藏
页码:277 / 286
页数:10
相关论文
共 87 条
[1]   Complement and complement regulatory proteins as potential molecular targets for vascular diseases [J].
Acosta, J ;
Qin, SB ;
Halperin, J .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (02) :203-211
[2]   Membranoproliferative glomerulonephritis type II (dense deposit disease):: An update [J].
Appel, GB ;
Cook, HT ;
Hageman, G ;
Jennette, JC ;
Kashgarian, M ;
Kirschfink, M ;
Lambris, JD ;
Lanning, L ;
Lutz, HU ;
Meri, S ;
Rose, NR ;
Salant, DJ ;
Sethi, S ;
Smith, RJH ;
Smoyer, W ;
Tully, HF ;
Tully, SP ;
Walker, P ;
Welsh, M ;
Würzner, R ;
Zipfel, PF .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1392-1403
[3]   Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis [J].
Bao, LH ;
Osawe, I ;
Haas, M ;
Quigg, RJ .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1947-1955
[4]   C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist [J].
Bao, LH ;
Osawe, I ;
Puri, T ;
Lambris, JD ;
Haas, M ;
Quigg, RJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (08) :2496-2506
[5]   Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice [J].
Bao, LH ;
Haas, M ;
Kraus, DM ;
Hack, BK ;
Rakstang, JK ;
Holers, VM ;
Quigg, RJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (03) :670-679
[6]   Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice [J].
Bao, LH ;
Haas, M ;
Boackle, SA ;
Kraus, DM ;
Cunningham, PN ;
Park, P ;
Alexander, JJ ;
Anderson, RK ;
Culhane, K ;
Holers, VM ;
Quigg, RJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3601-3607
[7]   Association between mannose-binding lectin levels and graft survival in kidney transplantation [J].
Berger, SP ;
Roos, A ;
Mallat, MJK ;
Fujita, T ;
de Fijter, JW ;
Daha, MR .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (06) :1361-1366
[8]  
Böhmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091
[9]  
Bottazzini U, 1998, B UNIONE MAT ITAL, V1A, P59
[10]   Influence of donor C3 allotype on late renal-transplantation outcome [J].
Brown, KM ;
Kondeatis, E ;
Vaughan, RW ;
Kon, SP ;
Farmer, CKT ;
Taylor, JD ;
He, X ;
Johnston, A ;
Horsfield, C ;
Janssen, BJC ;
Gros, P ;
Zhou, WD ;
Sacks, SH ;
Sheerin, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (19) :2014-2023